Orogentx
1 known investors
Find your way into Orogentx
Sign up to see every warm intro you have to Orogentx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orogentx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases. The company combines computational chemistry, DNA-encoded library technology, and medicinal expertise to develop novel therapeutic medicines.
Founders & leadership
MP
Mark PykettChief Executive Officer
Investors · 1
Frequently asked questions
- What does Orogentx do?
- Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases. The company combines computational chemistry, DNA-encoded library technology, and medicinal expertise to develop novel therapeutic medicines.
- Who are Orogentx's investors?
- Orogentx's investors include Novalis LifeSciences.